Short Interest in Avantor, Inc. (NYSE:AVTR) Declines By 13.2% - MarketBeat

2022-09-04 19:04:53 By : Mr. Johnson XU

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

Avantor, Inc. (NYSE:AVTR - Get Rating) was the target of a significant drop in short interest in July. As of July 31st, there was short interest totalling 8,700,000 shares, a drop of 13.2% from the July 15th total of 10,020,000 shares. Based on an average daily trading volume, of 5,270,000 shares, the days-to-cover ratio is currently 1.7 days. Wall Street Analysts Forecast Growth

AVTR has been the subject of several research analyst reports. Evercore ISI lowered their target price on Avantor to $35.00 in a research note on Tuesday, August 9th. TheStreet raised Avantor from a "c" rating to a "b-" rating in a research note on Thursday, May 19th. William Blair reaffirmed an "outperform" rating on shares of Avantor in a research note on Friday, April 29th. Cowen cut their target price on shares of Avantor to $39.00 in a research report on Tuesday, August 9th. Finally, Wells Fargo & Company lowered their target price on Avantor from $42.00 to $33.00 and set an "overweight" rating for the company in a research report on Monday, April 25th. One analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $39.00.Insider Activity at Avantor

In other news, EVP Frederic Vanderhaegen sold 39,000 shares of the company's stock in a transaction dated Monday, May 23rd. The shares were sold at an average price of $31.61, for a total value of $1,232,790.00. Following the sale, the executive vice president now directly owns 126,764 shares of the company's stock, valued at approximately $4,007,010.04. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, EVP Frederic Vanderhaegen sold 39,000 shares of the stock in a transaction dated Monday, May 23rd. The shares were sold at an average price of $31.61, for a total value of $1,232,790.00. Following the transaction, the executive vice president now directly owns 126,764 shares of the company's stock, valued at $4,007,010.04. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Gerard Brophy sold 19,603 shares of Avantor stock in a transaction that occurred on Friday, May 20th. The shares were sold at an average price of $31.27, for a total transaction of $612,985.81. Following the completion of the sale, the executive vice president now owns 96,935 shares of the company's stock, valued at $3,031,157.45. The disclosure for this sale can be found here. 1.60% of the stock is owned by company insiders. Institutional Trading of Avantor

Institutional investors have recently modified their holdings of the business. Baird Financial Group Inc. increased its position in shares of Avantor by 1.6% during the fourth quarter. Baird Financial Group Inc. now owns 18,115 shares of the company's stock valued at $763,000 after buying an additional 290 shares during the period. Signaturefd LLC lifted its holdings in shares of Avantor by 17.9% in the 1st quarter. Signaturefd LLC now owns 2,370 shares of the company's stock worth $80,000 after acquiring an additional 359 shares during the last quarter. Friess Associates LLC boosted its holdings in Avantor by 3.4% during the 1st quarter. Friess Associates LLC now owns 11,911 shares of the company's stock valued at $403,000 after acquiring an additional 396 shares during the period. Cigna Investments Inc. New increased its stake in shares of Avantor by 6.7% in the second quarter. Cigna Investments Inc. New now owns 6,679 shares of the company's stock worth $208,000 after buying an additional 419 shares during the period. Finally, Sheaff Brock Investment Advisors LLC grew its stake in shares of Avantor by 1.3% in the first quarter. Sheaff Brock Investment Advisors LLC now owns 35,677 shares of the company's stock worth $1,207,000 after purchasing an additional 443 shares during the last quarter. 93.24% of the stock is currently owned by hedge funds and other institutional investors. Avantor Stock Down 2.2 %

NYSE AVTR traded down $0.64 during trading hours on Tuesday, hitting $28.17. The company's stock had a trading volume of 260,194 shares, compared to its average volume of 6,617,493. The company has a current ratio of 1.64, a quick ratio of 1.05 and a debt-to-equity ratio of 1.41. The company's 50-day simple moving average is $30.22 and its two-hundred day simple moving average is $32.09. The company has a market capitalization of $18.99 billion, a PE ratio of 30.33, a price-to-earnings-growth ratio of 0.70 and a beta of 1.30. Avantor has a 52 week low of $27.50 and a 52 week high of $44.37.

Avantor (NYSE:AVTR - Get Rating) last issued its quarterly earnings results on Thursday, July 28th. The company reported $0.37 EPS for the quarter, missing analysts' consensus estimates of $0.38 by ($0.01). The business had revenue of $1.91 billion for the quarter, compared to analysts' expectations of $1.98 billion. Avantor had a net margin of 8.27% and a return on equity of 27.14%. The business's revenue was up 2.7% compared to the same quarter last year. During the same period in the previous year, the business posted $0.35 earnings per share. Research analysts anticipate that Avantor will post 1.46 EPS for the current fiscal year. Avantor Company Profile (Get Rating)

Avantor, Inc provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.Featured StoriesGet a free copy of the StockNews.com research report on Avantor (AVTR)Home Depot Results Point To Sluggish 2nd HalfWalmart Leads Retail Higher But Will The Group Follow? 3 Blowout Earnings Reports That Could Mark Turning PointsSkyworks Solutions Is Worth A Look At These Prices 3 Stocks Set to Lead the Nasdaq Bull Market

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Before you consider Avantor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.

While Avantor currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:

Tom remains optimistic about investors’ prospects going forward, even as the market reacts to the words of Fed Chair Jerome Powell about “pain ahead.”

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.